{"title":"非小细胞肺癌(NSCLC) 2年后停止或不停止免疫治疗?法国胸科肿瘤学家横断面调查结果。","authors":"S. Storme, D. Debieuvre, P. Souquet, S. Couraud","doi":"10.1183/13993003.congress-2022.600","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":229516,"journal":{"name":"11.01 - Lung cancer","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"To stop or not to stop immunotherapy after 2 years in Non Small Cell Lung Cancer (NSCLC)? Results of a cross sectional survey among French thoracic oncologist.\",\"authors\":\"S. Storme, D. Debieuvre, P. Souquet, S. Couraud\",\"doi\":\"10.1183/13993003.congress-2022.600\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":229516,\"journal\":{\"name\":\"11.01 - Lung cancer\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"11.01 - Lung cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2022.600\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"11.01 - Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2022.600","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
To stop or not to stop immunotherapy after 2 years in Non Small Cell Lung Cancer (NSCLC)? Results of a cross sectional survey among French thoracic oncologist.